Immune Repertoire Sequencing Market Growth

The immune repertoire sequencing market is projected to reach USD 3 billion by 2035, driven by government support for pharmacogenomics and growth in therapeutic areas. However, challenges include accuracy issues and lack of skilled personnel. The immunogenetics market is also experiencing significant growth due to advancements in genetic sequencing technologies and rising prevalence of autoimmune diseases. Opportunities include expansion of genetic medicine and integration of big data and AI.